This CME Activity has expired and is no longer available for credit.
Clinical Conversations on the Diagnosis and Management of Fibromyalgia: Focusing on Physician Assistants in Primary Care
Time to Complete
May 15, 2012
May 15, 2013
Fibromyalgia is frequently diagnosed and managed by primary care clinicians; however, research has shown that fibromyalgia is often not diagnosed or is diagnosed incorrectly. Studies further show that patients who are accurately diagnosed frequently receive therapies with limited benefit. This activity features a discussion between two fibromyalgia experts and has been developed to provide clinical insights into the diagnosis and management of patients who have fibromyalgia.
Upon completion of this activity, participants should be able to:
Identify the tools available for the accurate diagnosis of fibromyalgia and summarize the benefits and weaknesses of each
Differentiate between fibromyalgia and other conditions that share similar symptomatology
Explain the clinical utility of the updated American College of Rheumatology (ACR) guideline criteria for the diagnosis of fibromyalgia
Differentiate between fibromyalgia therapies that are efficacious and those that are not
In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Faculty Lindsey Gillispie, MHS, PA-C, has disclosed the following relevant financial relationships: Speaker: Abbott, Amgen, UCB Consultant: UCB
Joan McTigue, MS, PA-C, has disclosed the following relevant financial relationships: Speaker: Novartis, Takeda, URL Pharma
Ms. McTigue discusses the unlabeled or investigational use of a commercial product.
Richard S. Pope, MPAS, PA-C, DFAAPA, has disclosed the following relevant financial relationships: Advisor: Takeda, URL Pharma Speaker: Amgen, Takeda, UCB, URL Pharma
Mr. Pope discusses the unlabeled or investigational use of a commercial product.
Curatio CME Institute Thomas Finnegan, PhD, Associate Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Penn State College of Medicine Penn State staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Penn State College of Medicine, and Pfizer do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Penn State College of Medicine, or Pfizer. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Richard S. Pope, MPAS, PA-C, DFAAPA Physician Assistant Danbury Orthopedic Associates Adjunct Clinical Professor Quinnipiac University Danbury, Connecticut
Joan McTigue, MS, PA-C Division of Rheumatology University of Florida College of Medicine Gainesville, Florida
Steering Committee Richard S. Pope, MPAS, PA-C, DFAAPA—Chair
Lindsey Gillispie, MHS, PA-C Department of Rheumatology McBride Orthopedic Hospital Physicians Oklahoma City, Oklahoma
Joan McTigue, MS, PA-C
Jointly sponsored by
Support for this activity has been provided through an educational grant from Pfizer, Inc.
This activity has been designed to meet the educational needs of physician assistants and other health care providers involved in the diagnosis and management of fibromyalgia.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and Curatio CME Institute. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all pre-survey questions, post-test questions, completed the evaluation survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to the accreditation or your certificate for this activity, please contact Penn State at ContinuingEd@hmc.psu.edu or or (717) 531-6483. Reference course #G5017-12-T.